AllantoinvsTea Tree Oil

Allantoin (5-ureidohydantoin) stimulates cell proliferation and tissue regeneration by promoting fibroblast activity, keratinocyte proliferation, and extracellular matrix synthesis including collagen and glycosaminoglycans. It acts as a mild keratolytic by promoting the natural desquamation process—loosening corneocyte adhesion and facilitating shedding—without the irritation, pH disruption, or barrier compromise associated with alpha- or beta-hydroxy acids. Allantoin has anti-inflammatory properties through modulation of prostaglandin synthesis (inhibiting COX-2 and reducing PGE2) and may downregulate pro-inflammatory cytokines. Its moisturizing effect comes from increasing the water-binding capacity of the extracellular matrix and stratum corneum; it is highly soluble and forms hydrogen bonds with water. Allantoin also promotes wound epithelialization. Its safety profile—non-irritating, non-sensitizing, non-comedogenic—makes it suitable for compromised skin, post-procedure care, and infant formulations.

Terpinen-4-ol (30-40% of oil) disrupts bacterial membranes via phospholipid bilayer interaction, increasing permeability and potassium ion leakage. Bactericidal against Cutibacterium acnes, Staphylococcus aureus, and other skin pathogens — lipophilic terpenes penetrate bacterial envelope. Anti-inflammatory: suppresses TNF-alpha, IL-1beta, IL-8, PGE2 production in monocytes and keratinocytes via NF-kappa B and MAPK pathway inhibition. Reduces 5-lipoxygenase activity. Modulates skin microbiome — selective antimicrobial activity spares beneficial commensal flora. 1,8-cineole content should be low (<15%); high levels increase irritation. Clinical trials show 5% tea tree oil matches 5% benzoyl peroxide efficacy for inflammatory acne with fewer side effects, though onset is slower (8-12 weeks).